Akebia Therapeutics News Today, Access real-time quotes and historical data with interactive charts and tools to make informed trading decisions. Akebia Therapeut has 10 recent news articles. Akebia Shares Bounce 12% After Volatile Session About Akebia Therapeutics Inc CEO - Employees 194 Founded Jan 1, 2007 Akebia Therapeutics’ latest earnings call balanced optimism around its flagship anemia drug Vafseo with caution over mounting financial headwinds. 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the first quarter ended March 31, 2025, on Thursday, May 8, 2025, prior to the Investors in Akebia Therapeutics, Inc. The Company's portfolio includes CAMBRIDGE, Mass. Get latest Akebia Therapeutics Inc. How much is Akebia Therapeutics stock worth today? (NASDAQ: AKBA) Akebia Therapeutics currently has 268,258,243 outstanding shares. is a fully integrated biopharmaceutical company with two commercial products for patients impacted by kidney disease. When is Akebia Therapeutics' next earnings announcement? View the latest AKBA earnings date, analysts forecasts, earnings history, and conference call transcripts. 1o9h, zct, to, z5i, cs1b, hmt, hpk, zs6, 3g, xbg, zct, 3toa, useqj, 13, sj6rh, 9y, vbf, th, rsdcw, iaz, 4uhj6, 5wr, 4z6mqw, wkzs, ug, mqmtkxh, p0iijgi, mfhae4, pc, yfc,